Performance Assessment of FibriTimer™ Zeta-1 for PT and APTT Testing

The FibriTimer™ Zeta-1 (called ZETA1) is a new, semi-automated multipurpose Haemostasis system, indigenously developed featuring DUAL TECHNOLOGY. ZETA1 is designed and developed by a Bangalore MedTech Startup M/S Dfine Bio-innovations Pvt Ltd, keeping in mind the needs of smaller labs. ZETA1 has not yet been evaluated in India.The objective of this study was to evaluate the ZETA1 performance for prothrombin time (PT), activated partial thromboplastin time (APTT), and international normalized ratio (INR) under local laboratory conditions.For within run the CV% for normal control PT and APTT were 2.42 and 4.25 and 5.91 and 2.65 for abnormal control, respectively 4. For between runs on normal control, the CV% for PT and APTT were 0.76, 0.49, 2.34, and 0.99 for Abnormal control, respectivelyThe correlation coefficients of INR and APTT ratio between ZETA1 and CS-1600 were 0.96 and 0.81, respectively.Standard Error of INR and APTT Ratio were, i.e., 0.023 and 0.076, respectively.

Authors

Institutions

Publication Details

Journal
International Journal of Health Technology and Innovation
Published
2024-08-20
DOI
https://doi.org/10.60142/ijhti.v3i02.05
Primary Topic
Non-Destructive Testing Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Performance Assessment of FibriTimer™ Zeta-1 for PT and APTT Testing

S. H. Pai, Sudhindra
International Journal of Health Technology and Innovation
Non-Destructive Testing Techniques
article

Performance Assessment of FibriTimer™ Zeta-1 for PT and APTT Testing

S. H. Pai, Sudhindra
article en

Abstract

The FibriTimer™ Zeta-1 (called ZETA1) is a new, semi-automated multipurpose Haemostasis system, indigenously developed featuring DUAL TECHNOLOGY. ZETA1 is designed and developed by a Bangalore MedTech Startup M/S Dfine Bio-innovations Pvt Ltd, keeping in mind the needs of smaller labs. ZETA1 has not yet been evaluated in India.The objective of this study was to evaluate the ZETA1 performance for prothrombin time (PT), activated partial thromboplastin time (APTT), and international normalized ratio (INR) under local laboratory conditions.For within run the CV% for normal control PT and APTT were 2.42 and 4.25 and 5.91 and 2.65 for abnormal control, respectively 4. For between runs on normal control, the CV% for PT and APTT were 0.76, 0.49, 2.34, and 0.99 for Abnormal control, respectivelyThe correlation coefficients of INR and APTT ratio between ZETA1 and CS-1600 were 0.96 and 0.81, respectively.Standard Error of INR and APTT Ratio were, i.e., 0.023 and 0.076, respectively.

International Journal of Health Technology and InnovationVol. 3(02)
Institut de Technologie Alimentaire (SN), Manipal Hospital (IN)
Openalex Percentile: Top 78%
Non-Destructive Testing Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.